2 weeks Ago By ABMN Staff
Teacher Retirement System of Texas boosted its stake in Omnicell, Inc. ( NASDAQ:OMCL – Free Report ) by 59.0% in the fourth quarter, Holdings Channel reports.
The firm owned 26,682 shares of the company’s stock after purchasing an additional 9,896 shares during the quarter. Teacher Retirement System of Texas’ holdings in Omnicell were worth $1,188,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also bought and sold shares of the company.
Smartleaf Asset Management LLC raised its position in shares of Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock valued at $35,000 after buying an additional 273 shares in the last quarter.
Van ECK Associates Corp increased its stake in Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock valued at $44,000 after acquiring an additional 315 shares during the last quarter.
First Horizon Advisors Inc. lifted its stake in Omnicell by 36.3% during the fourth quarter.
First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock worth $59,000 after purchasing an additional 355 shares during the last quarter. KBC Group NV boosted its holdings in shares of Omnicell by 60.
8% in the 4th quarter. KBC Group NV now owns 2,057 shares of the company’s stock valued at $92,000 after purchasing an additional 778 shares in the last quarter. Finally, AlphaQuest LLC increased its stake in shares of Omnicell by 307.
8% in the 4th quarter. AlphaQuest LLC now owns 3,576 shares of the company’s stock valued at $159,000 after purchasing an additional 2,699 shares during the last quarter. Institutional investors own 97.
70% of the company’s stock. Analyst Ratings Changes Several analysts recently weighed in on the company. Bank of America dropped their price objective on Omnicell from $54.
00 to $46.00 and set a “neutral” rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co.
reduced their price target on shares of Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, March 20th.
Wells Fargo & Company decreased their price target on shares of Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th.
StockNews.com downgraded shares of Omnicell from a “buy” rating to a “hold” rating in a research note on Monday, March 24th. Finally, Benchmark reaffirmed a “buy” rating and set a $62.
00 target price on shares of Omnicell in a research note on Tuesday, February 4th. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.
com, the company has a consensus rating of “Hold” and an average target price of $51.00. Omnicell Stock Down 1.
0 % NASDAQ:OMCL opened at $35.01 on Friday. The company has a debt-to-equity ratio of 0.
13, a current ratio of 1.37 and a quick ratio of 1.22.
Omnicell, Inc. has a one year low of $25.12 and a one year high of $55.
75. The firm’s 50 day simple moving average is $39.01 and its 200 day simple moving average is $42.
57. The company has a market cap of $1.64 billion, a PE ratio of 129.
67, a P/E/G ratio of 7.53 and a beta of 0.85.
Omnicell ( NASDAQ:OMCL – Get Free Report ) last issued its quarterly earnings results on Thursday, February 6th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.
57 by ($0.12). Omnicell had a return on equity of 3.
82% and a net margin of 1.13%. On average, research analysts anticipate that Omnicell, Inc.
will post 1.09 earnings per share for the current year. Omnicell Profile ( Free Report ) Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. Featured Articles Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc.
( NASDAQ:OMCL – Free Report ). Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter .
.
